Memantine Hydrochloride
NDC 71610-979, memantine hydrochloride, tablet, film coated, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-979
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200022
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-979 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEMANTINE HYDROCHLORIDE5 mg/1
Pharmacologic classes
N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-979-80 | 71610097980 | 180 TABLET, FILM COATED in 1 BOTTLE (71610-979-80) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71610-979 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-979 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-979. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.